Lifeward Ltd

Lifeward Ltd's capital structure is characterized by a debt-to-equity ratio of 0.33, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.31, suggesting it can cover its short-term obligations but with limited buffer. The company's cash and equivalents amount to $2.17 million, while its long-term debt is $2.80 million, resulting in a net cash position that is negative after subtracting total debt. Profitability metrics for Lifeward Ltd are weak, with a return on equity (ROE) of -2.37 and a return on assets (ROA) of -0.87, both significantly below the industry median for medical equipment and supplies. The company reported a net loss of $19.91 million and an operating loss of $19.67 million, indicating a challenging operating environment. Gross profit of $8.43 million on $22.03 million in revenue suggests a gross margin of 38.3%, which is in line with the industry but insufficient to offset operating costs. Geographically and segment-wise, the company's revenue concentration is not disclosed in the available data. However, the absence of segment-specific revenue breakdowns limits the ability to assess geographic or product diversification. The company operates in a single business sector, which may increase its exposure to sector-specific risks. The company's growth trajectory is uncertain, with no specific revenue growth or decline figures provided for the current or next fiscal year. The operating cash flow of -$16.83 million and free cash flow of -$19.60 million indicate a cash outflow, which could constrain the company's ability to invest in growth initiatives. The capital expenditure of -$16,000 is minimal, suggesting limited investment in physical assets. Risk factors for Lifeward Ltd include liquidity constraints and the potential for dilution, although the latter is currently assessed as low. The company's negative net cash position after subtracting total debt is a key flag, indicating potential challenges in maintaining liquidity. The absence of strong buy recommendations from analysts and the presence of only two buy ratings suggest a cautious outlook from the investment community. Recent events and filings do not provide specific details on material developments for Lifeward Ltd. The company's financial performance and operational results are disclosed in its latest financial statements, but no significant events or earnings call transcripts are highlighted in the available data.